Tvardi Therapeutics

(NASDAQ) TVRD

Current Price$3.58

Market Cap$33.49M

Since IPO (2025)-80%

5 Year-99%

1 Year-89%

1 Month+11%

Tvardi Therapeutics Financials at a Glance

Market Cap

$33.49M

Revenue (TTM)

$0.00

Net Income (TTM)

$15.44M

EPS (TTM)

$-3.09

P/E Ratio

-1.15

Dividend

$0.00

Beta (Volatility)

0.51 (Low)

Dividend

$0.00

Beta (Volatility)

0.51 (Low)

Price

$3.58

Volume

48,522.818

Open

$3.60

Price

$3.58

Volume

48,522.818

Open

$3.60

Previous Close

$3.57

Daily Range

$3.42 - $3.83

52-Week Range

$2.75 - $43.65

Dividend

$0.00

Beta (Volatility)

0.51 (Low)

Price

$3.58

Volume

48,522.818

Open

$3.60

Previous Close

$3.57

Daily Range

$3.42 - $3.83

52-Week Range

$2.75 - $43.65

TVRD News

Tvardi Posts Q2 Net Income Turnaround

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tvardi Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Imran Alibhai, PhD

Website

tvarditherapeutics.com

Headquarters

Sugar Land, TX 77021, US

TVRD Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-480%

Return on Capital

-2%

Return on Assets

-60%

Earnings Yield

-86.96%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$33.49M

Shares Outstanding

9.38M

Volume

48.52K

Avg. Volume

47.85K

Financials (TTM)

Gross Profit

$95.00K

Operating Income

$26.75M

EBITDA

$26.65M

Operating Cash Flow

$23.50M

Capital Expenditure

$0.00

Free Cash Flow

$23.50M

Cash & ST Invst.

$30.81M

Total Debt

$201.00K

Tvardi Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$33.49M

N/A

Market Cap/Employee

$1.97M

N/A

Employees

N/A

Net Income

$6.80M

-38.7%

EBITDA

$7.05M

-245.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$24.81M

+280.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$54.00K

-99.8%

Short Term Debt

$120.00K

+13.2%

Return on Assets

-59.80%

N/A

Return on Invested Capital

-2.02%

N/A

Free Cash Flow

$5.68M

-40.6%

Operating Cash Flow

$5.68M

-40.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

FGENFibroGen, Inc.

FGENFibroGen, Inc.$9.07-1.63%

LTRNLantern Pharma Inc.

LTRNLantern Pharma Inc.$3.50+5.42%

LVTXLAVA Therapeutics N.V.

LVTXLAVA Therapeutics N.V.$1.74-3.87%

XLOXilio Therapeutics, Inc.

XLOXilio Therapeutics, Inc.$8.25-3.79%

ELUTElutia Inc.

ELUTElutia Inc.$1.16-3.33%

CALCCalciMedica, Inc.

CALCCalciMedica, Inc.$0.63-0.17%

TPSTTempest Therapeutics, Inc.

TPSTTempest Therapeutics, Inc.$1.86+2.76%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$15.47+0.09%

FFord Motor Company

FFord Motor Company$14.93+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

INTCIntel

INTCIntel$119.84+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

ACHRArcher Aviation

ACHRArcher Aviation$6.36+0.04%

Questions About TVRD

What is the current price of Tvardi Therapeutics?

Tvardi Therapeutics is trading at $3.57 per share.

What is the 52-week range for Tvardi Therapeutics?

Over the past 52 weeks, Tvardi Therapeutics has traded between $2.75 and $43.65.

How much debt does Tvardi Therapeutics have?

As of the most recent reporting period, Tvardi Therapeutics reported total debt of $174,000.

How much cash does Tvardi Therapeutics have on hand?

Tvardi Therapeutics reported $19.85M in cash and cash equivalents in its most recent financial results.

What is Tvardi Therapeutics’s dividend yield?

Tvardi Therapeutics does not currently have a dividend yield.

Tvardi Therapeutics

Tvardi Therapeutics Financials at a Glance

TVRD News

Tvardi Posts Q2 Net Income Turnaround

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Tvardi Therapeutics

TVRD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Tvardi Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TVRD

What is the current price of Tvardi Therapeutics?

What is the 52-week range for Tvardi Therapeutics?

How much debt does Tvardi Therapeutics have?

How much cash does Tvardi Therapeutics have on hand?

What is Tvardi Therapeutics’s dividend yield?

Premium Investing Services